Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Caligiuri

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentW Hans Meisen, Eric S Wohleb, Alena Cristina Jaime-Ramirez, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Nature Communications|November 28, 2018
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearanceLuke Russell, Jessica Swanner, Alena Cristina Jaime-Ramirez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2015
Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicitySaranya Elavazhagan, Kavin Fatehchand, Vikram Santhanam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Blood|March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentW Hans Meisen, Eric S Wohleb, Alena Cristina Jaime-Ramirez, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Nature Communications|November 28, 2018
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearanceLuke Russell, Jessica Swanner, Alena Cristina Jaime-Ramirez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2015
Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicitySaranya Elavazhagan, Kavin Fatehchand, Vikram Santhanam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Blood|March 13, 2012
Regulation of acute graft-versus-host disease by microRNA-155Parvathi Ranganathan, Catherine E A Heaphy, Stefan Costinean, et al.
Pageof 3